The Flavivirus Protease As a Target for Drug Discovery

被引:0
|
作者
Matthew Brecher [1 ]
Jing Zhang [1 ]
Hongmin Li [1 ,2 ]
机构
[1] Wadsworth Center,New York State Department of Health
[2] Department of Biomedical Sciences,School of Public Health,State University of New York
关键词
Flavivirus; Inhibitor; Protease;
D O I
暂无
中图分类号
R91 [药物基础科学];
学科分类号
1007 ;
摘要
Many flaviviruses are significant human pathogens causing considerable disease burdens,including encephalitis and hemorrhagic fever,in the regions in which they are endemic.A paucity of treatments for flaviviral infections has driven interest in drug development targeting proteins essential to flavivirus replication,such as the viral protease.During viral replication,the flavivirus genome is translated as a single polyprotein precursor,which must be cleaved into individual proteins by a complex of the viral protease,NS3,and its cofactor,NS2B.Because this cleavage is an obligate step of the viral life-cycle,the flavivirus protease is an attractive target for antiviral drug development.In this review,we will survey recent drug development studies targeting the NS3 active site,as well as studies targeting an NS2B/NS3interaction site determined from flavivirus protease crystal structures.
引用
收藏
页码:326 / 336
页数:11
相关论文
共 50 条
  • [1] The Flavivirus Protease As a Target for Drug Discovery
    Matthew Brecher
    Jing Zhang
    Hongmin Li
    Virologica Sinica, 2013, 28 (06) : 326 - 336
  • [2] The flavivirus polymerase as a target for drug discovery
    Malet, Helene
    Masse, Nicolas
    Selisko, Barbara
    Romette, Jean-Louis
    Alvarez, Karine
    Guillemot, Jean Claude
    Tolou, Hughes
    Yap, Thai Leong
    Vasudevan, Subash
    Lescar, Julien
    Canard, Bruno
    ANTIVIRAL RESEARCH, 2008, 80 (01) : 23 - 35
  • [3] Novel approaches to flavivirus drug discovery
    Botting, Carolyn
    Kuhn, Richard J.
    EXPERT OPINION ON DRUG DISCOVERY, 2012, 7 (05) : 417 - 428
  • [4] Molecular targets for flavivirus drug discovery
    Sampath, Aruna
    Padmanabhan, R.
    ANTIVIRAL RESEARCH, 2009, 81 (01) : 6 - 15
  • [5] New developments in flavivirus drug discovery
    Kok, W. Mei
    EXPERT OPINION ON DRUG DISCOVERY, 2016, 11 (05) : 433 - 445
  • [6] Autophagy protease ATG4B as a target in drug discovery
    Freeman, Jamie
    Kriston-Vizi, Janos
    Lindenschmidt, Ida
    Haider, Mursleen
    Ketteler, Robin
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2011, 28 : S72 - S72
  • [7] The flavivirus NS2B-NS3 protease-helicase as a target for antiviral drug development
    Luo, Dahai
    Vasudevan, Subhash G.
    Lescar, Julien
    ANTIVIRAL RESEARCH, 2015, 118 : 148 - 158
  • [8] Protease inhibitors in drug discovery
    Tavares, FX
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (16) : 1587 - 1587
  • [9] Active site exploration and inhibitor discovery for a novel Scabies aspartyl protease drug target
    Goldfarb, Nathan
    Mahmood, Wajahat
    Dunn, Ben M.
    FASEB JOURNAL, 2011, 25
  • [10] Hepatitis C virus NS3 serine protease as a drug discovery target
    McPhee, F
    Yeung, KS
    Good, AC
    Meanwell, NA
    DRUGS OF THE FUTURE, 2003, 28 (05) : 465 - 488